Insulin secretion in maturity-onset-diabetes. Function of isolated islets. 1980

D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig

An impaired insulin response to glucose is a characteristic finding in maturity onset diabetes (MOD). To clarify whether the decreased insulin response in vivo is related to a primary defect of the beta-cells, isolated islets of MOD - obtained by intraoperative biopsy - were examined for their insulin content, biosynthesis and release. The in vitro experiments showed that despite a missing or significantly reduced insulin response in vivo the isolated beta-cells of the same patients had a normal insulin content, a normal or even high biosynthesis, and insulin release could be induced by glucose. These results suggest that the primary defect in MoD cannot be related to an intrinsic failure of the beta-cells to response to glucose; extrapancreatic factors seem to influence their reaction to glucose. These factors may be of a higher level in those patients or the reaction of the beta-cells is more inhibited by the same concentrations in diabetic patients.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
January 1983, Journees annuelles de diabetologie de l'Hotel-Dieu,
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
March 1981, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
January 2012, Methods in molecular biology (Clifton, N.J.),
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
February 1991, Annals of medicine,
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
January 1984, Minerva endocrinologica,
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
January 1990, Diabetes,
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
September 1969, Acta diabetologica latina,
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
March 1981, Journal of the Indian Medical Association,
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
November 1982, Chinese medical journal,
D Lohmann, and H Jahr, and H J Verlohren, and S Schmidt, and W Heilmann, and H Zühlke, and W Hartig, and H Mättig
December 1971, La Presse medicale,
Copied contents to your clipboard!